This section of the site contains important safety information regarding Remicade (infliximab).


For a full list of reported side effects please see the Remicade Summary of Product Characteristics and/or the Patient Information Leaflet.

Your patient alert card contains important safety information. This should be read and carried with you and shown to any healthcare professional who is involved in your care. Please ask your healthcare professional for an alert card if you do not have one.

As with all medicines, you might experience some side effects with Remicade. Some of these might happen during treatment, and some in between your treatments.

Most side effects - if you experience any at all - are mild to moderate. As with other medicines, some side effects can be severe. So it is important to know what the possible side effects are, so that if you do experience one you can let your healthcare professional know.

Some of the side effects seen with Remicade treatment are listed below:

  • Increased risk of infections. Tell your healthcare professional immediately if you experience fever, sore throat, cough or feel generally unwell. These can be signs of an infection which requires prompt treatment
  • Pain in the joints, muscles or back
  • Reactions where the drip enters your arm such as pain, swelling, redness or itching
  • Changes in blood test results in some patients, including a fall in the number of red or white cells, or both
  • Change in blood pressure or heart rate (this will be monitored during your treatment)
  • Headache
  • Eye problems, including red eyes and infections
  • Feeling tired or weak
  • Stomach pain, feeling sick, diarrhoea, and indigestion
  • Changes in sensation such as feeling dizzy or having problems sleeping
  • Dry skin or eczema
  • Rarely, some patients treated with Remicade have developed certain kinds of skin cancer, therefore you should have your skin examined from time to time. Please inform your doctor if you notice any changes in the appearance of the skin or growths on the skin during or after therapy
  • Remicade, like other anti-TNF biologics, may increase the risk of certain cancers. Very rarely some patients with Crohn's disease or ulcerative colitis have developed a very serious type of cancer called hepatosplenic T-cell lymphoma, which has usually resulted in death


Remicade is a prescription-only medicine and must be used under medical supervision.

Reporting of side effects:

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.